Journal article
Enoxaparin Versus Dabigatran or Rivaroxaban for Thromboprophylaxis After Hip or Knee Arthroplasty
Abstract
BACKGROUND: Dabigatran and rivaroxaban are novel oral anticoagulants approved for prevention of venous thromboembolism after hip or knee arthroplasty. However, information assessing clinically important efficacy and bleeding outcomes of these 2 new agents versus low-molecular-weight heparin (enoxaparin) is lacking.
METHODS AND RESULTS: We separately pooled efficacy and safety data from 6 phase III randomized trials (18 405 participants) …
Authors
Huisman MV; Quinlan DJ; Dahl OE; Schulman S
Journal
Circulation Cardiovascular Quality and Outcomes, Vol. 3, No. 6, pp. 652–660
Publisher
Wolters Kluwer
Publication Date
November 2010
DOI
10.1161/circoutcomes.110.957712
ISSN
1941-7713